Logo (3).png
Real-world Evidence (RWE) Solutions Market to Reach $3.13 Billion by 2027, Growing at a CAGR of 16.5%, Says Meticulous Research®
March 15, 2021 08:30 ET | Meticulous Market Research Pvt. Ltd.
Redding, California, March 15, 2021 (GLOBE NEWSWIRE) -- According to a new market research report, “Real-world Evidence (RWE) Solutions Market by Component [Datasets, EMR, Services], Application...
Logo (3).png
In-vitro Diagnostics (IVD) Reagents Market Worth $77.6 billion by 2027, Growing at a CAGR of 7% From 2020, Says Meticulous Research®
March 15, 2021 07:12 ET | Meticulous Market Research Pvt. Ltd.
London, March 15, 2021 (GLOBE NEWSWIRE) -- According to a new market research report “In-Vitro Diagnostic Reagents Market by Type (Oligonucleotide, Antibodies, Nucleic Acid Probe), Technology...
Axim-Sapphire_Logo_-04 (1).png
AXIM® Biotechnologies Successfully Completes Point-of-Care Clinical Trials on its Rapid COVID-19 Neutralizing Antibody Test
March 08, 2021 09:00 ET | AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, March 08, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting...
FBI LOGO TM.png
COVID-19 Diagnostics Market Size Worth USD 8.04 Billion at 2.7% CAGR; Pharmaceutical Giants Such as Abbott and Roche to Pump More Funds for R&D Activities: Fortune Business Insights™
March 01, 2021 06:57 ET | Fortune Business Insights
Pune, India, March 01, 2021 (GLOBE NEWSWIRE) -- The global COVID-19 diagnostics market size is projected to reach USD 8.04 billion by 2027, exhibiting a CAGR of 2.7% during the forecast period....
FBI LOGO TM.png
COVID-19 Diagnostics Market 2021 Size & Share | Market worth USD 11.40 Billion at 7.9% CAGR by 2027
February 09, 2021 04:33 ET | Fortune Business Insights
Pune, India, Feb. 09, 2021 (GLOBE NEWSWIRE) -- The global COVID-19 diagnostics market is projected to reach USD 8.04 billion by 2027, exhibiting a CAGR of 2.7% during the forecast period....
Axim-Sapphire_Logo_-04 (1).png
AXIM® Biotechnologies Begins Clinical Trials on Its ImmunoPass Rapid Diagnostic Test With Vaccine Recipients
February 03, 2021 09:00 ET | AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Feb. 03, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological...
FBI LOGO TM.png
Global COVID-19 Diagnostics Market Size Worth USD 11.40 Billion at 7.9% CAGR; Pharmaceutical Giants Such as Abbott and Roche to Pump More Funds for R&D Activities: Fortune Business Insights™
January 19, 2021 06:05 ET | Fortune Business Insights
Pune, India, Jan. 19, 2021 (GLOBE NEWSWIRE) -- The global COVID-19 diagnostics market size is projected to reach USD 11.40 billion by 2027, exhibiting a CAGR of 7.9% during the forecast period....
FBI LOGO TM.png
COVID-19 Diagnostics Market Worth USD 8.04 Billion with Rise at 2.7% CAGR till 2027; Pharmaceutical Giants Such as Abbott and Roche to Pump More Funds for R&D Activities: Fortune Business Insights™
October 26, 2020 07:34 ET | Fortune Business Insights
Pune, Oct. 26, 2020 (GLOBE NEWSWIRE) -- The global COVID-19 diagnostics market size is projected to reach USD 8.04 billion by 2027, exhibiting a CAGR of 2.7% during the forecast period. ...
FBI LOGO TM.png
COVID-19 Diagnostics Market to Hit USD 11.40 Billion by 2027; Growing Urgency for Efficient Testing of Symptomatic COVID Patients to Boost the Market: Fortune Business Insights™
July 17, 2020 12:13 ET | Fortune Business Insights
Pune, July 17, 2020 (GLOBE NEWSWIRE) -- The global COVID-19 diagnostics market size is projected to reach USD 11.40 billion by 2027, exhibiting a CAGR of 7.9% during the forecast period....
Gibson Logo.png
Gibson Diagnostic Labs Provides Recommendations on How to Safely Reopen Practices
July 07, 2020 11:45 ET | Gibson Diagnostic Labs
IRVING, TX, July 07, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Keeping patients and staff safe is always our priority here at Gibson Diagnostic Labs. Now, it is even more important than ever.  ...